Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2012

Ardea Biosciences, Inc. (RDEA) Starts Presentation at the Noble 8th Annual Equity Conference

Ardea Biosciences, Inc. (NASDAQ: RDEA) is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases. The Company’s most advanced clinical-stage product candidates include RDEA594 for the chronic management of hyperuricemia and gout; BAY … Continue reading

Posted in Noble Equity Conference | Leave a comment

Imation Corp. (IMN) Starts Presentation at the Noble 8th Annual Equity Conference

Imation Corp. (NYSE: IMN) is a worldwide technology company helping individuals store, protect and connect their digital world. In addition to the Imation brand, the Company’s portfolio includes the Memorex brand and the XtremeMac brand. Imation is also the exclusive … Continue reading

Posted in Noble Equity Conference | Leave a comment

RELM Wireless Corp. (RWC) Starts Presentation at the Noble 8th Annual Equity Conference

RELM Wireless Corp. (AMEX: RWC) produces high specification two way communications equipment for use by public safety professionals and government agencies, as well as radios for use in a wide range of commercial and industrial applications. Advances include a broad … Continue reading

Posted in Noble Equity Conference | Leave a comment

Entercom Communications Corp. (ETM) Starts Presentation at the Noble 8th Annual Equity Conference

Entercom Communications Corp. (NYSE: ETM) is numbered among the five largest radio broadcasting companies in the United States. Entercom is home to some of the most compelling personalities and illustrious brands in radio, and the company has broadcast partnerships with … Continue reading

Posted in Noble Equity Conference | Leave a comment

PAR Technology Corp. (PAR) Starts Presentation at the Noble 8th Annual Equity Conference

PAR Technology Corp. (NYSE: PAR) provides technology solutions in a variety of areas, from hospitality to government defense. PAR’s hospitality segment has been a top provider of restaurant and retail technology for more than three decades. PAR also offers hotel … Continue reading

Posted in Noble Equity Conference | Leave a comment

BioCryst Pharmaceuticals, Inc. (BCRX) Starts Presentation at the Noble 8th Annual Equity Conference

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) specializes in developing, designing and optimizing novel small-molecule pharmaceuticals to block the key enzymes that play a role in inflammatory diseases, infectious diseases and cancer. BioCryst is currently developing three novel late-stage compounds that treat … Continue reading

Posted in Noble Equity Conference | Leave a comment

CPI Aerostructures, Inc. (CVU) Starts Presentation at the Noble 8th Annual Equity Conference

CPI Aerostructures, Inc. (NYSE Amex: CVU) is a contract producer of structural aircraft parts. CPI Aero serves leading prime defense contractors, the U.S. Air Force and other branches of the armed forces, also acting as a subcontractor in the production … Continue reading

Posted in Noble Equity Conference | Leave a comment

Hanger Orthopedic Group, Inc. (HGR) Starts Presentation at the Noble 8th Annual Equity Conference

Hanger Orthopedic Group, Inc. (NYSE: HGR) is one of the world’s foremost providers of services and products enhancing human physical capability. Hanger specializes in orthotic and prosthetic patient care services, distributing O&P devices and components, and bringing therapeutic solutions to … Continue reading

Posted in Noble Equity Conference | Leave a comment

FalconStor Software (FALC) Starts Presentation at the Noble 8th Annual Equity Conference

FalconStor Software, Inc. (NASDAQ: FALC) leads the market in disk-based data protection. FalconStor solutions are built upon an award-winning platform and provide disk-based backup, continuous data protection, WAN-optimized replication and disaster recovery automation. The Company’s focus is bringing backup and … Continue reading

Posted in Noble Equity Conference | Leave a comment

Savient Pharmaceuticals, Inc. (SVNT) Starts Presentation at the Noble 8th Annual Equity Conference

Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA® for the treatment of chronic gout. Savient has exclusive worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University and … Continue reading

Posted in Noble Equity Conference | Leave a comment